VM26 therapy in children with drug-refractory lymphocytic leukemia
- 1 April 1982
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 7 (2-3) , 169-172
- https://doi.org/10.1007/bf00254541
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Childhood acute lymphocytic leukemia: progress and problems in treatment.1981
- POOR OUTLOOK FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA WITH RELAPSEThe Medical Journal of Australia, 1979
- Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (all)Medical and Pediatric Oncology, 1979
- Effects of the Epipodophyllotoxin Derivative VM 26 in Mitosis and in InterphaseOncology, 1978
- Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213Published by Elsevier ,1975
- Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.The Journal of cell biology, 1975
- 4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.1975
- Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemiaCancer, 1967
- The role of vincristine in the treatment of childhood acute leukemiaClinical Pharmacology & Therapeutics, 1966
- Vincristine in the treatment of acute leukemia in childrenCancer, 1963